Universe Pharmaceuticals INC (NASDAQ:UPC) Stock Short Interest Report for September

Universe Pharmaceuticals INC (NASDAQ:UPC) saw a large decline in short interest during the month of September. As of September 30th, there was short interest totaling 43,865 shares, a decline of 42.2% from the September 15th total of 75,844 shares. Approximately 2.0% of the shares of the stock are sold short. Based on an average trading volume of 40,506 shares, the short-interest ratio is presently 1.1 days.

Universe Pharmaceuticals Price Performance

Universe Pharmaceuticals stock traded down $0.22 during midday trading on Friday, hitting $3.93. 7,807 shares of the company were exchanged, compared to its average volume of 42,726. The business has a fifty day simple moving average of $4.74 and a two-hundred day simple moving average of $4.08. Universe Pharmaceuticals has a fifty-two week low of $2.00 and a fifty-two week high of $17.96. The company has a quick ratio of 3.90, a current ratio of 4.05 and a debt-to-equity ratio of 0.04.

Universe Pharmaceuticals (NASDAQ:UPC) last released its quarterly earnings results on Wednesday, July 29th. The company reported ($1.38) EPS for the quarter. The company had revenue of $4.52 million for the quarter.

Analysts Set New Price Targets

UPC has been the subject of a number of analyst reports. Weiss Ratings raised shares of Universe Pharmaceuticals from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, July 29th. Wall Street Zen upgraded Universe Pharmaceuticals to a “hold” rating in a research note on Saturday, August 29th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Universe Pharmaceuticals has an average rating of “Sell”.

About Universe Pharmaceuticals

Universe Pharmaceuticals Inc (NASDAQ: UPC) is a China-based pharmaceutical company engaged in the development, manufacture and sale of traditional Chinese medicine (TCM) products and other healthcare offerings. The company serves consumers primarily through pharmaceutical distributors, retail pharmacies and other sales channels in China.

Universe Pharmaceuticals’ product portfolio includes over-the-counter and prescription pharmaceutical products, as well as healthcare and nutritional products.